ZWHC:CA:TSX-BMO Covered Call Health Care ETF (CAD)

ETF | Others |

Last Closing

CAD 28.77

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.14 (+0.53%)

CAD 6.19B
XEQT:CA iShares Core Equity Portfolio

+0.19 (+0.56%)

CAD 5.85B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.02 (+0.03%)

CAD 5.48B
PHYS-U:CA Sprott Physical Gold Trust

-0.08 (-0.40%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.08 (+0.21%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

-0.14 (-0.31%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.02 (+0.20%)

CAD 3.29B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.01 (+0.02%)

CAD 2.98B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.07 (+0.31%)

CAD 2.78B

ETFs Containing ZWHC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.27% 26% F 31% F
Dividend Return 5.74% 84% B 78% C+
Total Return 9.01% 34% F 36% F
Trailing 12 Months  
Capital Gain 3.41% 28% F 31% F
Dividend Return 6.33% 83% B 80% B-
Total Return 9.74% 35% F 36% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.91% 44% F 40% F
Dividend Return 2.30% 44% F 35% F
Total Return 0.39% 73% C 28% F
Risk Return Profile  
Volatility (Standard Deviation) 4.31% 86% B+ 94% A
Risk Adjusted Return 53.27% 71% C- 66% D+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.